Gilliam Joseph E: insider trades.
Gilliam Joseph E reported 7 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($10.8M), across 2 companies.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 2
- Companies
- 2
- Name as filed
- Gilliam Joseph E
Companies
| Company | Relationship | Transactions |
|---|---|---|
| GLAUKOS Corp (GKOS) | Officer · PRESIDENT & COO | 6 |
| Caris Life Sciences, Inc. (CAI) | Director | 1 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-14 | Caris Life Sciences, Inc. | A | 13,192 | $0 | 29,321 | Form 4 |
| 2026-08-11 | GLAUKOS Corp | S | 32,037 | $180.49 | 72,588 | Form 4 |
| 2026-08-11 | GLAUKOS Corp | M | 10,000 | $48.46 | 82,588 | Form 4 |
| 2026-08-11 | GLAUKOS Corp | M | 20,000 | $55.18 | 102,588 | Form 4 |
| 2026-08-11 | GLAUKOS Corp | S | 27,963 | $178.89 | 104,625 | Form 4 |
| 2026-08-11 | GLAUKOS Corp | M | 20,000 | $55.18 | 122,588 | Form 4 |
| 2026-08-11 | GLAUKOS Corp | M | 10,000 | $48.46 | 132,588 | Form 4 |
Questions
What stock did Gilliam Joseph E buy or sell?
Gilliam Joseph E reported 7 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($10.8M), across 2 companies.
Is Gilliam Joseph E the same person as other filers with this name?
This page covers SEC CIK 1705850 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/gilliam-joseph-e-1705850.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.